Difficulty: Medium
Average Score: 86%
Practice
Angiotensin II plays a key role in the following risk factor for ischaemic heart disease
Correct answer
B
Rationale
Angiotensin II plays a key role in the risk factor for ischaemic heart disease known as ventricular hypertrophy. This is because Angiotensin II is a potent vasoconstrictor that leads to increased afterload on the heart, causing the left ventricle to work harder to pump blood. Over time, this can result in ventricular hypertrophy, a condition where the heart muscle thickens in response to increased workload, ultimately increasing the risk of ischaemic heart disease.
Regarding the other options:
A) Hypercholesterolemia is a risk factor for ischaemic heart disease, but it is not directly related to the role of Angiotensin II.
C) Carbohydrate intolerance is not directly linked to the role of Angiotensin II in ischaemic heart disease.
D) Cardiac arrhythmia is a potential complication of ischaemic heart disease but is not directly influenced by Angiotensin II in the context of this question.
In an educational context, understanding the role of Angiotensin II in cardiovascular physiology is crucial for healthcare professionals, especially those working with patients at risk for cardiovascular diseases. By recognizing how Angiotensin II contributes to ventricular hypertrophy and subsequently to ischaemic heart disease, healthcare providers can implement appropriate interventions to manage these conditions effectively.
Regarding the other options:
A) Hypercholesterolemia is a risk factor for ischaemic heart disease, but it is not directly related to the role of Angiotensin II.
C) Carbohydrate intolerance is not directly linked to the role of Angiotensin II in ischaemic heart disease.
D) Cardiac arrhythmia is a potential complication of ischaemic heart disease but is not directly influenced by Angiotensin II in the context of this question.
In an educational context, understanding the role of Angiotensin II in cardiovascular physiology is crucial for healthcare professionals, especially those working with patients at risk for cardiovascular diseases. By recognizing how Angiotensin II contributes to ventricular hypertrophy and subsequently to ischaemic heart disease, healthcare providers can implement appropriate interventions to manage these conditions effectively.